|
GB9606452D0
(en)
*
|
1996-03-27 |
1996-06-05 |
Sandoz Ltd |
Organic compounds
|
|
DE69736750T2
(de)
|
1996-07-30 |
2007-08-16 |
Novartis Ag |
Pharmazeutische zusammensetzungen zur behandlung der transplantatabstossung sowie der autoimmun- oder entzündlichen zustände
|
|
US20030129215A1
(en)
*
|
1998-09-24 |
2003-07-10 |
T-Ram, Inc. |
Medical devices containing rapamycin analogs
|
|
US6890546B2
(en)
|
1998-09-24 |
2005-05-10 |
Abbott Laboratories |
Medical devices containing rapamycin analogs
|
|
AU4565000A
(en)
*
|
1999-05-10 |
2000-11-21 |
Novartis Ag |
Organic compounds
|
|
US7807211B2
(en)
|
1999-09-03 |
2010-10-05 |
Advanced Cardiovascular Systems, Inc. |
Thermal treatment of an implantable medical device
|
|
US20070032853A1
(en)
*
|
2002-03-27 |
2007-02-08 |
Hossainy Syed F |
40-O-(2-hydroxy)ethyl-rapamycin coated stent
|
|
US6790228B2
(en)
|
1999-12-23 |
2004-09-14 |
Advanced Cardiovascular Systems, Inc. |
Coating for implantable devices and a method of forming the same
|
|
US20030229393A1
(en)
*
|
2001-03-15 |
2003-12-11 |
Kutryk Michael J. B. |
Medical device with coating that promotes cell adherence and differentiation
|
|
US8460367B2
(en)
*
|
2000-03-15 |
2013-06-11 |
Orbusneich Medical, Inc. |
Progenitor endothelial cell capturing with a drug eluting implantable medical device
|
|
US20070141107A1
(en)
*
|
2000-03-15 |
2007-06-21 |
Orbusneich Medical, Inc. |
Progenitor Endothelial Cell Capturing with a Drug Eluting Implantable Medical Device
|
|
US20070055367A1
(en)
*
|
2000-03-15 |
2007-03-08 |
Orbus Medical Technologies, Inc. |
Medical device with coating that promotes endothelial cell adherence and differentiation
|
|
US7037332B2
(en)
|
2000-03-15 |
2006-05-02 |
Orbus Medical Technologies, Inc. |
Medical device with coating that promotes endothelial cell adherence
|
|
US8088060B2
(en)
|
2000-03-15 |
2012-01-03 |
Orbusneich Medical, Inc. |
Progenitor endothelial cell capturing with a drug eluting implantable medical device
|
|
US9522217B2
(en)
|
2000-03-15 |
2016-12-20 |
Orbusneich Medical, Inc. |
Medical device with coating for capturing genetically-altered cells and methods for using same
|
|
US8236048B2
(en)
|
2000-05-12 |
2012-08-07 |
Cordis Corporation |
Drug/drug delivery systems for the prevention and treatment of vascular disease
|
|
US7300662B2
(en)
|
2000-05-12 |
2007-11-27 |
Cordis Corporation |
Drug/drug delivery systems for the prevention and treatment of vascular disease
|
|
US20050002986A1
(en)
*
|
2000-05-12 |
2005-01-06 |
Robert Falotico |
Drug/drug delivery systems for the prevention and treatment of vascular disease
|
|
US6670355B2
(en)
*
|
2000-06-16 |
2003-12-30 |
Wyeth |
Method of treating cardiovascular disease
|
|
US20020013335A1
(en)
*
|
2000-06-16 |
2002-01-31 |
American Home Products Corporation |
Method of treating cardiovascular disease
|
|
EP1709974A3
(en)
*
|
2000-06-16 |
2006-12-06 |
Wyeth |
Method of treating cardiovascular disease using rapamycin
|
|
WO2002026139A1
(en)
|
2000-09-29 |
2002-04-04 |
Cordis Corporation |
Coated medical devices
|
|
LT2269604T
(lt)
|
2001-02-19 |
2016-11-10 |
Novartis Ag |
Inkstų solidinių navikų gydymas rapamicino dariniu
|
|
US8741378B1
(en)
|
2001-06-27 |
2014-06-03 |
Advanced Cardiovascular Systems, Inc. |
Methods of coating an implantable device
|
|
US6939376B2
(en)
|
2001-11-05 |
2005-09-06 |
Sun Biomedical, Ltd. |
Drug-delivery endovascular stent and method for treating restenosis
|
|
US7682387B2
(en)
*
|
2002-04-24 |
2010-03-23 |
Biosensors International Group, Ltd. |
Drug-delivery endovascular stent and method for treating restenosis
|
|
RU2315621C2
(ru)
*
|
2002-02-22 |
2008-01-27 |
Профи Мед Аб |
Применение ингибитора или антагониста тканевого фактора
|
|
US20040024450A1
(en)
*
|
2002-04-24 |
2004-02-05 |
Sun Biomedical, Ltd. |
Drug-delivery endovascular stent and method for treating restenosis
|
|
WO2003099169A1
(en)
*
|
2002-05-20 |
2003-12-04 |
Orbus Medical Technologies Inc. |
Drug eluting implantable medical device
|
|
US8109987B2
(en)
|
2003-04-14 |
2012-02-07 |
Tryton Medical, Inc. |
Method of treating a lumenal bifurcation
|
|
US7279174B2
(en)
|
2003-05-08 |
2007-10-09 |
Advanced Cardiovascular Systems, Inc. |
Stent coatings comprising hydrophilic additives
|
|
US20050118344A1
(en)
|
2003-12-01 |
2005-06-02 |
Pacetti Stephen D. |
Temperature controlled crimping
|
|
US7220755B2
(en)
*
|
2003-11-12 |
2007-05-22 |
Biosensors International Group, Ltd. |
42-O-alkoxyalkyl rapamycin derivatives and compositions comprising same
|
|
US9114198B2
(en)
|
2003-11-19 |
2015-08-25 |
Advanced Cardiovascular Systems, Inc. |
Biologically beneficial coatings for implantable devices containing fluorinated polymers and methods for fabricating the same
|
|
TW200605910A
(en)
*
|
2004-04-30 |
2006-02-16 |
Orbus Medical Technologies Inc |
Medical device with coating for capturing genetically-altered cells and methods for using same
|
|
EP1768662A2
(en)
|
2004-06-24 |
2007-04-04 |
Novartis Vaccines and Diagnostics, Inc. |
Small molecule immunopotentiators and assays for their detection
|
|
US8709469B2
(en)
|
2004-06-30 |
2014-04-29 |
Abbott Cardiovascular Systems Inc. |
Anti-proliferative and anti-inflammatory agent combination for treatment of vascular disorders with an implantable medical device
|
|
US7901451B2
(en)
*
|
2004-09-24 |
2011-03-08 |
Biosensors International Group, Ltd. |
Drug-delivery endovascular stent and method for treating restenosis
|
|
US20060194829A1
(en)
*
|
2004-12-20 |
2006-08-31 |
Clackson Timothy P |
Therapeutic materials and methods
|
|
JP5709354B2
(ja)
|
2005-11-14 |
2015-04-30 |
アリアド・ファーマシューティカルズ・インコーポレイテッド |
ｍＴＯＲ阻害剤投与によるがん患者の治療
|
|
WO2007058399A1
(en)
*
|
2005-11-17 |
2007-05-24 |
Access Plus Co., Ltd |
A tube for connecting marteriovenous and interposition for medical operation
|
|
US20070173923A1
(en)
*
|
2006-01-20 |
2007-07-26 |
Savage Douglas R |
Drug reservoir stent
|
|
EP2431036B1
(en)
|
2006-09-13 |
2017-04-12 |
Elixir Medical Corporation |
Macrocyclic lactone compounds and methods for their use
|
|
US8067055B2
(en)
*
|
2006-10-20 |
2011-11-29 |
Biosensors International Group, Ltd. |
Drug-delivery endovascular stent and method of use
|
|
US20080097591A1
(en)
|
2006-10-20 |
2008-04-24 |
Biosensors International Group |
Drug-delivery endovascular stent and method of use
|
|
US20080103584A1
(en)
|
2006-10-25 |
2008-05-01 |
Biosensors International Group |
Temporal Intraluminal Stent, Methods of Making and Using
|
|
KR100930167B1
(ko)
*
|
2007-09-19 |
2009-12-07 |
삼성전기주식회사 |
초광각 광학계
|
|
US8661630B2
(en)
|
2008-05-21 |
2014-03-04 |
Abbott Cardiovascular Systems Inc. |
Coating comprising an amorphous primer layer and a semi-crystalline reservoir layer
|
|
EP3459572A1
(en)
|
2007-11-14 |
2019-03-27 |
Biosensors International Group, Ltd. |
Automated coating method
|
|
US8921642B2
(en)
*
|
2008-01-11 |
2014-12-30 |
Massachusetts Eye And Ear Infirmary |
Conditional-stop dimerizable caspase transgenic animals
|
|
EP2352459A4
(en)
*
|
2008-10-03 |
2013-09-25 |
Elixir Medical Corp |
MACROCYCLIC LACTONE COMPOUNDS AND METHODS OF USE
|
|
US8382818B2
(en)
|
2009-07-02 |
2013-02-26 |
Tryton Medical, Inc. |
Ostium support for treating vascular bifurcations
|
|
US8685433B2
(en)
|
2010-03-31 |
2014-04-01 |
Abbott Cardiovascular Systems Inc. |
Absorbable coating for implantable device
|
|
UA104738C2
(ru)
|
2011-05-18 |
2014-03-11 |
Олег Миколайович Лазаренко |
Композиция для повышения биосовместимости имплантатов и клеток для трансплантации с организмом реципиента и способ ее приготовления
|
|
CN102268015B
(zh)
*
|
2011-08-30 |
2013-08-28 |
成都摩尔生物医药有限公司 |
一种依维莫司的合成方法
|
|
US10682415B2
(en)
|
2013-07-22 |
2020-06-16 |
Wisconsin Alumni Research Foundation |
Thermogel formulation for combination drug delivery
|
|
KR101723265B1
(ko)
|
2013-08-16 |
2017-04-04 |
가톨릭대학교 산학협력단 |
mTOR/STAT3 신호억제제 처리된 면역조절능을 갖는 간엽줄기세포 및 이를 포함하는 면역질환의 예방 또는 치료용 세포치료제 조성물
|
|
KR102323291B1
(ko)
|
2013-09-24 |
2021-11-05 |
기너 라이프 사이언시즈, 인크. |
세포 임플란트의 기체 처리를 위한 시스템
|
|
EP3738592B1
(en)
|
2013-10-08 |
2022-01-26 |
AI Therapeutics, Inc. |
Rapamycin for the treatment of lymphangioleiomyomatosis
|
|
JP2017505789A
(ja)
|
2014-02-11 |
2017-02-23 |
ラム・セラピューティクス，インコーポレーテッド |
リンパ脈管筋腫症の治療のためのラパマイシン
|
|
US10307371B2
(en)
|
2014-02-11 |
2019-06-04 |
AI Therapeutics, Inc. |
Rapamycin for the treatment of lymphangioleiomyomatosis
|
|
BR112016022598A8
(pt)
|
2014-04-04 |
2021-06-29 |
Ai Therapeutics Inc |
composição aerossol farmacêutica na forma de um pó seco para liberação pulmonar, forma de dosagem unitária, pacote farmacêutico, kit e uso
|
|
CA2963085C
(en)
|
2014-10-07 |
2023-02-21 |
Lam Therapeutics, Inc. |
An inhalable rapamycin formulation for the treatment of pulmonary hypertension
|
|
MA40910A
(fr)
|
2014-11-07 |
2017-09-12 |
Civitas Therapeutics Inc |
Poudres de rapamycine pour administration pulmonaire
|
|
WO2016130645A1
(en)
|
2015-02-10 |
2016-08-18 |
Lam Therapeutics, Inc. |
Rapamycin for the treatment of lymphangioleiomyomatosis
|
|
CN109689053A
(zh)
|
2016-08-10 |
2019-04-26 |
得克萨斯州大学系统董事会 |
局部雷帕霉素疗法
|
|
US12453624B2
(en)
|
2016-09-19 |
2025-10-28 |
Biotronik Ag |
Polymer-free drug eluting vascular stents
|
|
MX2019005676A
(es)
|
2016-11-15 |
2019-09-10 |
Giner Life Sciences Inc |
Dispositivo percutáneo de difusión de gases adecuado para su uso con un implante subcutáneo.
|
|
EP3558407B1
(en)
|
2016-12-22 |
2023-03-15 |
Biotronik AG |
Drug releasing coatings for medical devices and methods of making same
|
|
JP7199632B2
(ja)
|
2017-05-04 |
2023-01-06 |
ガイナー，インク． |
堅牢なインプラント可能なガス送達装置ならびにそれを含む方法、システムおよび装置
|
|
UY37900A
(es)
|
2017-09-26 |
2019-04-30 |
Novartis Ag |
Nuevos derivados de rapamicina
|
|
AU2019409366B2
(en)
|
2018-12-18 |
2022-10-27 |
Novartis Ag |
Rapamycin derivatives
|
|
US20200261427A1
(en)
|
2019-02-20 |
2020-08-20 |
Al Therapeutics, Inc. |
Topical rapamycin formulations and their use in treating facial angiofibromas and other skin disorders
|